Development of Stem Cell Therapies for Retinal Degeneration

  1. Robin R. Ali1,2
  1. 1Division of Molecular Therapy, UCL Institute of Ophthalmology, London EC1V 9EL, United Kingdom
  2. 2Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan 48105, USA
  1. Correspondence: r.ali{at}ucl.ac.uk

Abstract

Degenerative retinal disease is the major cause of sight loss in the developed world and currently there is a lack of effective treatments. As the loss of vision is directly the result of the loss of retinal cells, effective cell replacement through stem-cell-based therapies may have the potential to treat a great number of retinal diseases whatever their underlying etiology. The eye is an ideal organ to develop cell therapies as it is immune privileged, and modern surgical techniques enable precise delivery of cells to the retina. Furthermore, a range of noninvasive diagnostic tests and high-resolution imaging techniques facilitate the evaluation of any therapeutic intervention. In this review, we evaluate the progress to date of current cell therapy strategies for retinal repair, focusing on transplantation of pluripotent stem-cell-derived retinal pigment epithelium (RPE) and photoreceptor cells.



Also in this Collection

      | Table of Contents

      In this Collection